NDC product
Nystatin and Triamcinolone Acetonide
NDC 0316-0223 · Crown Laboratories
Key facts
| Product NDC | 0316-0223 |
|---|---|
| Proprietary name | Nystatin and Triamcinolone Acetonide |
| Nonproprietary name | Nystatin and Triamcinolone Acetonide |
| Substances | NYSTATIN, TRIAMCINOLONE ACETONIDE |
| Dosage form | CREAM |
| Route | TOPICAL |
| Labeler | Crown Laboratories |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Application number | ANDA207730 |
| Pharmacologic classes | Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polyene Antifungal [EPC], Polyenes [CS] |
| Marketing start | Jan 2, 2018 |
| Listing certified through | Dec 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: